Pluribus Labs’s Greif GEF Stock Holding History

Pluribus Labs’s Portfolio GEF Stock Details GEF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,437	Closed	-$389K	–	127
2021 Q4	$389K	Buy	+6,437	New	+$417K	0.41%	86

Other funds holding GEF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Pluribus Labs's GEF Position: Q1 2022 in Review

Pluribus Labs sold out of Greif (GEF) in Q1 2022, closing a stake of 6,437 shares — an estimated $389K sold.

Pluribus Labs first reported a position in GEF in Q4 2021 and held it in 1 quarter. The position peaked at $389K in Q4 2021. 211 funds tracked by Wall St. Rank hold GEF as of Q1 2022.

Pluribus Labs reported no remaining Greif position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 6,437 Greif shares in Q1 2022, an estimated $389K.
Pluribus Labs first reported a position in Greif in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Greif position peaked at $389K in Q4 2021.
211 funds tracked by Wall St. Rank held Greif as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.